Related Experiment Video

Updated: Feb 26, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.2K

Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure

Naama Rotem-Kohavi1,2, Tim F Oberlander2,3,4

  • 1Graduate Program in Neuroscience, University of British Columbia, Vancouver, BC.

Birth Defects Research
|July 18, 2017
PubMed

Insights

Selective serotonin reuptake inhibitor (SSRI) antidepressants used during pregnancy may impact child neurodevelopment. Some children show effects, while others do not, indicating a need for further research into risk factors.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Pharmacology

Background:

  • Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) for mood disorders presents neurodevelopmental risks.
  • Distinguishing drug effects from maternal mood and environment is challenging in human studies.
  • Serotonin's role in development suggests potential impacts of SSRI exposure on early brain development.

Purpose of the Study:

  • To review the long-term neurobehavioral effects in childhood following prenatal SSRI exposure.
  • To explore emerging research distinguishing medication effects from genetic and environmental factors.
  • To identify factors influencing developmental risk or benefit from maternal SSRI treatment.

Main Methods:

  • Review of existing literature on prenatal SSRI exposure and childhood neurodevelopmental outcomes.
  • Analysis of studies differentiating medication effects from maternal mood and environmental influences.
  • Examination of research on genetic, maternal, and environmental moderators of SSRI effects.

Main Results:

  • Prenatal SSRI exposure shows varied neurobehavioral outcomes in children; not all are affected.
  • Emerging research is beginning to disentangle the effects of medication from genetics and environment.
  • Some children may be at developmental risk, while others might benefit from maternal SSRI treatment.

Conclusions:

  • Long-term neurodevelopmental effects of prenatal SSRI exposure are complex and variable.
  • Further research is crucial to identify specific risk and protective factors.
  • Understanding these factors will aid in personalized treatment decisions for pregnant individuals with mood disorders.

Keywords:
child behaviorchild developmentmaternal depressionpregnancyprenatal SSRI exposure

More Related Videos

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development05:44

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development

Published on: May 17, 2024

1.2K
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.8K

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
57
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.4K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
780